ECIO 2020 - PRELIMINARY PROGRAMME C RSE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
LEADERS IN ONCOLOGIC INTERVENTIONS ECIO 2020 European Conference on Interventional Oncology April 26-29 Nice, France www.ecio.org PRELIMINARY PROGRAMME C RSE Cardiovascular and Interventional Radiological Society of Europe
LE AD E R S I N O N CO LO G I C
Interventional oncology is continuously growing, frequently oncologic field. It will once again explore a plethora of clinical
branching into new areas and making exciting progress. subjects, from well-established therapies, such as local ablation
Staying up-to-date on all of these constant changes can be for HCC, to newer clinical areas, such as immunotherapy and
challenging; in order to facilitate conversation and push the advances in nuclear medicine.
envelope for innovation even further, the European Conference
on Interventional Oncology (ECIO) offers a wide range of Focus on curative treatments
oncological specialists a comprehensive forum for education,
networking and exchange. The ECIO 2020 programme also recognises the expanding
role of minimally invasive treatments in tackling cancer
Since its first meeting in 2008, ECIO has evolved from a small, head-on. As in previous years, Clinical Focus Sessions
yet significant biennial meeting of IRs into the leading annual examining HCC procedures, such as Hepatocarcinoma: from
congress in the field of interventional oncology, bringing a classification to treatment, will provide an excellent model for
multidisciplinary group of nearly 1,500 healthcare professionals how interventional oncology can achieve quality outcomes
from 65 countries together to learn and discuss the latest topics in cancer care. Other sessions, such as Nuclear medicine and
and future advancements in IO. With the upcoming congress interventional oncology – present and future, will explore new
in Nice, France, ECIO hopes to expand on this success, creating data and expert advice on some of the field’s latest and most
a space for professionals across an even broader range of promising treatment possibilities which continue to enhance
disciplines to meet and work toward innovations in cancer care. the overall impact of interventional oncology for patients.
The Scientific Programme Committee has been working Another exciting aspect of the ECIO 2020 programme is a
diligently to create an expansive scientific programme covering Clinical Focus Session titled Upcoming European Research,
a broad spectrum of relevant topics for all those working in the which will provide the opportunity for young researchers
A. Denys P.L. Pereira D. Arnold T. Bilhim D.J. Breen P. Chevallier T. de Baère A. Gangi
Committees
Scientific Programme Committee Local Host Committee
Alban Denys (CH), Chairperson Patrick Chevallier (Nice), Chairperson
Philippe L. Pereira (DE), Deputy Chairperson Sophie Aufort (Montpellier)
Dirk Arnold (DE) Christophe Cassinotto (Montpellier)
Tiago Bilhim (PT) Pascal Chabrot (Clermont-Ferrand)
David J. Breen (UK) Audrey Fohlen (Caen)
Patrick Chevallier (FR) Boris Guiu (Montpellier)
Thierry de Baère (FR) Fabrice Lame (Nice)
Afshin Gangi (FR) Maxime Ronot (Clichy)
Thomas J. Kroencke (DE) Vania Tacher (Créteil)
Martijn R. Meijerink (NL) Vincent Vidal (Marseille)
Franco Orsi (IT)
Lambros Tselikas (FR)I NTE RV E NTI O N S
to present their latest work, delving into timely topics such Our beautiful host city
as intratumoral immunotherapy, cryo-priming in immuno-
response and endothelial antibody capture. This session will Located on the French Rivera, the picturesque city of Nice
help us look forward, both examining the implications of provides an ideal backdrop for ECIO 2020. As a top location
current developments and the future possibilities of the field for both business and leisure, Nice is connected to France’s
at large. second largest airport, Nice Côte d‘Azur, linking the city with
direct service to 90 cities in 40 countries. As the congress will
Expanding opportunities to share research be hosted at the award-winning Acropolis Exhibition Centre,
it can be conveniently accessed from the city centre by a major
As a new feature, ECIO 2020 allowed attendees to submit tramline.
abstracts in the form of a case report – in addition to scientific
abstracts and educational abstracts – bringing the submission In collaboration with our travel partner Kuoni DMC, we have
types in line with the CIRSE annual congress. All accepted reserved the most ideally situated and comfortable congress
case reports, as well as educational abstracts and select hotels, ensuring a pleasurable stay throughout your time in
scientific abstracts, will be available for public viewing at this stunning and dynamic city.
the congress, providing authors the opportunity to receive
comments directly from the onsite workstations. We hope We look forward to welcoming you to Nice!
that this will give a diverse group of IRs and oncology On se retrouve à Nice!
specialists the opportunity to share their research and receive
valuable feedback.
T.J. Kroencke M.R. Meijerink F. Orsi L. Tselikas
Advisory Board Content
Andreas Adam (UK) 2 Preliminary Faculty
Thierry de Baère (FR)
Johannes Lammer (AT)
3 Honorary Lecture
Jan H. Peregrin (CZ) 4 Collaborating Against Cancer Initiative
Jim A. Reekers (NL) 5 10 reasons why you can’t miss ECIO 2020
6-7 Timetable
9-21 Scientific Programme
22 Basic Course
23 Hands-on Device Training
24 Safe Sedation
25 Registration / CME / Important Addresses
26-27 Accommodation / City Map2 Preliminary Faculty European Conference on Interventional Oncology
Preliminary Faculty
Subject to change
Abadal J.M. (Madrid/ES) Gahide G. (Montreal/CA) Meijerink M.R. (Amsterdam/NL)
Adam A. (London/UK) Gambardella V. (Valencia/ES) Muglia R. (Rozzano/IT)
Adema G. (Nijmegen/NL) Gangi A. (Strasbourg/FR) Narayanan G. (Miami, FL/US)
Akhan O. (Ankara/TR) Garcia-Monaco R. (Buenos Aires/AR) Nielsen T.K. (Aarhus/DK)
Arai Y. (Tokyo/JP) Garin E. (Rennes/FR) Orsi F. (Milan/IT)
Arnold D. (Hamburg/DE) Garnon J. (Strasbourg/FR) Ottensmeier C. (Southampton/UK)
Ayuso C. (Barcelona/ES) Gaubert J.Y. (Marseille/FR) Palussière J. (Bordeaux/FR)
Bale R. (Innsbruck/AT) Goldberg N. (Jerusalem/IL) Park S.J. (Incheon/KR)
Bargellini I. (Pisa/IT) Golfieri R. (Bologna/IT) Pereira P.L. (Heilbronn/DE)
Barnacle A.M. (London/UK) Grasso R.F. (Rome/IT) Pinto Marques H. (Lisbon/PT)
Bauones S. (Riad/SA) Graumann O. (Odense/DK) Poretti D. (Rozzano/IT)
Bell J. (Manchester/UK) Guiu B. (Montpellier/FR) Rao P.P. (Colmar/FR)
Bex A. (Amsterdam/NL) Guthrie A. (Leeds/UK) Reimer P. (Karlsruhe/DE)
Bilhim T. (Lisbon/PT) Haanen J. (Amsterdam/NL) Ricke J. (Munich/DE)
Breen D.J. (Southampton/UK) Haen S. (Tübingen/DE) Ronot M. (Clichy/FR)
Bridgewater J. (London/UK) Hakimé A. (Villejuif/FR) Salem R. (Chicago, IL/US)
Brody J. (New York, NY/US) Helmberger T.K. (Munich/DE) Sangro B. (Pamplona/ES)
Brountzos E. (Athens/GR) Heymann S. (Strasbourg/FR) Schaefer N. (Lausanne/CH)
Bryant T. (Southampton/UK) Hocquelet A. (Lausanne/CH) Scheffer H.J. (Amsterdam/NL)
Burrel M. (Barcelona/ES) Hoffmann R.-T. (Dresden/DE) Schmit G.D. (Rochester, MN/US)
Buy X. (Bordeaux/FR) Iannelli A. (Nice/FR) Seror O. (Bondy/FR)
Callstrom M.R. (Rochester, MN/US) Iezzi R. (Rome/IT) Sofocleous C.T. (New York, NY/US)
Cazzato R.L. (Strasbourg/FR) Ikeda M. (Tokyo/JP) Solbiati L. (Rozzano/IT)
Cervelli R. (Pisa/IT) Ilhan H. (Munich/DE) Solomon S.B. (New York, NY/US)
Champiat S. (Villejuif/FR) Ilyas S. (London/UK) Sommer C.-M. (Heidelberg/DE)
Chapiro J. (New Haven, CT/US) Jakobs T.F. (Munich/DE) Sone M. (Tokyo/JP)
Chevallier P. (Nice/FR) Jayankura M. (Brussels/BE) Stedman B. (Southampton/UK)
Coimbra E. (Lisbon/PT) Jennings J.W. (St. Louis, MO/US) Suh R.D. (Los Angeles, CA/US)
Correas J.-M. (Paris/FR) Jenniskens S. (Nijmegen/NL) Tacher V. (Creteil/FR)
Crocetti L. (Pisa/IT) Kazemier G. (Amsterdam/NL) Tanaka T. (Kashihara/JP)
Curigliano G. (Milan/IT) Kelekis A.D. (Athens/GR) Tselikas L. (Villejuif/FR)
de Baère T. (Villejuif/FR) Kenny L.M. (Brisbane/AU) Tsoumakidou G. (Lausanne/CH)
de Boo D.W. (New Lambton Heights/AU) King A. (Southampton/UK) Urbano J. (Madrid/ES)
de Jong K. (Groningen/NL) Kroencke T.J. (Augsburg/DE) Válek V. (Brno/CZ)
Denys A. (Lausanne/CH) Kurup A.N. (Rochester, MN/US) van Lienden K.P. (Amsterdam/NL)
Deschamps F. (Villejuif/FR) Laasch H.-U. (Manchester/UK) van Strijen M.J.L. (Nieuwegein/NL)
Digklia A. (Lausanne/CH) Lam M.G.E.H. (Utrecht/NL) Varano G.M. (Milan/IT)
Douane F. (Nantes/FR) Lee F.T. (Madison, WI/US) Vauthey J.-N. (Houston, TX/US)
Doyen J. (Nice/FR) Lencioni R. (Pisa/IT) Wacker F. (Hannover/DE)
Dudderidge T. (Southampton/UK) Luz J.H. (Lisbon/PT) Wah T.M. (Leeds/UK)
Duran R. (Lausanne/CH) Mahnken A.H. (Marburg/DE) Wood B.J. (Bethesda, MD/US)
Filippiadis D.K. (Athens/GR) Malagari K. (Athens/GR) Woodward E. (Manchester/UK)
Fohlen A. (Caen/FR) Maleux G. (Leuven/BE) Yamakado K. (Osaka/JP)
Fuchs M. (Munich/DE) Martens U. (Heilbronn/DE)
Fütterer J.J. (Nijmegen/NL) Mauri G. (Milan/IT)
Preliminary ProgrammeECIO 2020 3
Honorary Lecture
Katerina Malagari
Katerina Malagari is a graduate from the National and She has written 98 scopus-indexed articles, including 30 pieces
Kapodistrian University of Athens Medical School. After on chemoembolisation and bland embolisation of liver tumors,
achieving her radiology board certification in 1990, three articles on prostatic embolisation, eight on non-vascular
she went to Birmingham, Alabama, for a fellowship in chest liver interventions, three on pharmacokinetics, one on an
imaging, followed by a two-year fellowship in interventional animal study, 16 on chest interventions, three on EVAR,
radiology at Athens University’s Department of Radiology. and 34 on diagnostic radiology, with an author index of 27
Prof. Malagari finished her PhD in 1992 and obtained the and 3,261 citations (3,162 without self citations).
EBIR diploma in 2010.
In total, 30 of Prof. Malagari’s articles have been featured in
In 2007, Prof. Malagari became the president of the European Greek journals. She has supervised 46 postgraduate MSCs
Society of Thoracic Imaging. She is a member of the editorial and nine PhDs and participated in nine multicenter projects
board of five international journals and has been awarded with European countries and the US.
“best published study of the year” on five separate occasions.
Another one of her notable accomplishments was being Prof. Malagari has shared her experience around the
part of the team that first introduced EVAR in Greece. world through her prolific didactic activity including
She was awarded the title of Distinguished 103 invited lectures in Greece and 114 lectures at
CIRSE Fellow in 2015. international congresses.
Katerina Malagari has written eleven Greek and five
international books. Since 2007, her research work has focused
on interventional radiology, chest and interventional oncology.
Honorary Lecture
History of chemoembolisation of the liver:
novelties and clinical practice – the evolution
of research methodology
Monday, April 27
10:30-11:30ECIO 2020
Collaborating Against Cancer Initiative
€100,000 in Educational Grants
CIRSE supports the “Collaborating Against Cancer” initiative with €100,000!
The ECIO initiative allows interventional radiologists with a full registration
for ECIO 2020 in Nice to invite their non-radiologist colleague to the conference
free of charge.
The first 100 referring physicians to sign up will receive free registration
and up to €1,000 in travel support.
“This programme allowed my oncologist colleague to gain
more awareness about the developments and possibilities
in interventional oncology.”
Christiaan van der Leij | Interventional Radiologist
“This initiative is very important because we can get the
newest insights and background information necessary
to counsel patients as optimally as possible.”
Judith de Vos-Geelen | Oncologist
For further information and registration
visit www.ecio.org10 reasons why you
can’t miss ECIO 2020
1 Offering a strong focus 6 Sharing research
ECIO offers a uniquely focused look at the fourth As the leading platform for scientific exchange in
pillar of cancer care, providing a platform for interventional oncology, ECIO will offer a keen look
experts in interventional radiology and other medical at the available data, with numerous clinical focus
specialties to come together and discuss minimally sessions examining the latest study and trial results. In
invasive IO treatments for a wide range the dedicated session on upcoming European research,
of malignancies. attendees will get a first glimpse at where IO research
is heading on the continent in the years to come.
2 Creating solid knowledge
With 18 clinical and technical focus sessions, ECIO 2020
7 Offering a variety of session formats
attendees will have the opportunity to widen their ECIO offers a variety of formats, each geared at
knowledge on every aspect of IO treatment, receiving optimally encouraging learning and knowledge
pointers on the nitty-gritty of various procedures, exchange. Session types include Clinical and Technical
tips and tricks on tools and materials, and learning Focus Sessions, Basic Courses, and Free Paper Sessions,
from their colleague’s experience in case-based as well as a Video Learning Session.
discussions.
8 Stimulating interaction
3 Providing hands-on experience ECIO attendees are strongly encouraged to engage in
For those itching to try out their newly acquired the programme by asking the faculty questions in
knowledge, ECIO 2020 will offer numerous person or via the app for a lively debate at the end
opportunities to gain practical experience in device of each session.
trainings sessions. Topics will include image guidance,
microwave ablation, RFA, and cryo-and laser ablation.
9 Creating strong allies
4 Exploring immuno-oncology The Collaborating against Cancer Initiative (CACI)
allows interventional radiologists attending ECIO to
In IO 4 IO, a dedicated session on immuno-oncology bring a colleague from their tumour board to the
in IO, a panel of experts will examine the ideal drugs congress free of charge. It is the perfect opportunity
and routes for immunotherapy, and will scrutinise the for IOs to show their colleagues what interventional
results that have been gained in this relatively new oncology has to offer, creating strong allies to advance
field of interventional oncology. minimally invasive approaches in the fight against
cancer.
5 Examining curative treatments
Recognising the expanding role of minimally invasive
10 Showing you all that’s new
treatments in curative cancer treatments, a Clinical Boasting the world’s largest IO exhibition, ECIO offers
Focus Session will delve into curative treatment in a unique look at everything device and materials
oligometastatic bone disease, examining the ideal manufacturers have to offer and a great opportunity
candidate for local treatment, the right tools, avoiding to liaise with the industry through dedicated learning
complications and potential challenges in follow-up. centres.Sunday, April 26 Monday, April 27
30
45
08:00
15 Satellite Symposia
30
45
09:00 CF 101 CF 801 CF 802 SED 4
Metastatic colorectal cancer Cholangio- IO 4 IO Safe Sedation
15 carcinoma application during
IR procedures
30 (basic)
45
p9 p13 p13 p24
10:00
15 Break Break
30
45
CF 201 TF 202 TA-HDT 1 SED 1 HL 901 TA-HDT 3 SED 5
11:00 Cancer Image Tumour Safe Sedation Honorary Lecture Tumour ablation: Safe Sedation
immuno- guidance: ablation: application Microwave application during
15 therapy: case-based Radio- during IR p14 IR procedures
30 clinical results discussion frequency procedures (advanced)
(basic) FP 902 Free Paper
45 Session 1
p9 p9 p23 p24 p14 p23 p24
12:00
Lunch break
15
30 Lunch break EM 1001
45 ECIO meets JSIR
p14
13:00
15 SED 6
Satellite Symposium SED 2 Satellite Symposium
30 Safe Sedation
Safe Sedation application
45 application during IR
during IR
14:00 procedures
procedures
Satellite Symposium Satellite Symposium (advanced/
(basic)
15 Propofol)
p24 p24
30
45 Break Break
15:00
15
CF 401 CF 402 TA-HDT 2 SED 3
30 Hepato- Other organs Tumour Safe Sedation CF 1101 CF 1102 TA-HDT 4
carcinoma: ablation ablation: application
45 Primary lung IO to optimise Tumour ablation:
from Radio- during IR tumours liver surgery Microwave
16:00 classification frequency procedures
to treatment (advanced)
15
p10 p11 p23 p24 p15 p15 p23
30
45 Break Break
17:00
15
30 CF 501 CF 502 BC 503 CF 1201 CF 1202 BC 1203
HCC: patient Nuclear medicine Basic Course: Robotics and AI MSK: curative Basic Course:
45 management and interventional Genitourinary treatment in Genitourinary
oncology – present oligometastatic
18:00 and future bone disease
15
p11 p12 p16 p16
30
45
Satellite Symposia p22 Satellite Symposia p22
19:00
15
30
e-voting Sessions include lectures that are recommended for EBIR preparation
Preliminary ProgrammeTuesday, April 28 Wednesday, April 29
30
45
08:00
15 Satellite Symposia
30
45
09:00 CF 1501 CF 1502 TF 2101 CF 2102
Renal cancer ablation: Upcoming European Tips and tricks: Different ways of killing
15 moving forward research case-based discussion cancer – and why we need
30 all of them
45
p17 p17 p21 p21
10:00
15 Break Break
30
45
11:00
CF 1601 CF 1602 TA-HDT 5 MM 2201
15 Challenges Palliation Tumour ablation: Morbidity & Mortality Conference
in IO in oncology Cryo- and laser
30
45
p18 p18 p23 p21
12:00
15
30 Lunch break
45
13:00
15
Satellite Symposium
30
45
14:00
Satellite Symposium
15
30
45 Break
15:00
15
30
CF 1801 VL 1802 TA-HDT 6
45 MSK palliation: How I do it Tumour ablation:
the pelvic bone Image guidance
16:00
15
p19 p19 p23
30
45 Break
17:00 CF: Clinical Focus Session
15 TF: Technical Focus Session
30 CF 1901 FP 1902 BC 1903 VL: Video Learning Session
Imaging and Free Paper Basic Course: HL: Honorary Lecture
45 clinical follow-up Session 2 Genitourinary
EM: ECIO meets
18:00 HDT: Hands-on Device Training
15 SED: Safe Sedation Training
p20 p20
30 BC: Basic Course
45 FP: Free Paper Session
Satellite Symposia p22 MM: Morbidity and Mortality
19:00
15
30European Board of
Interventional Radiology
Apply Now
and boost your career in IR
The EBIR is a globally recognised certification designed
to give practising IRs the opportunity to certify their
expertise and build their career.
Upcoming examinations:
• March 2020 – ECR
• September 2020 – CIRSE
• March 2021 – ECR
Submit your application online at
www.cirse.org/ebir
C RSE CESMA
U E M S
Cardiovascular and Interventional Radiological Society of EuropeECIO 2020 Sunday, April 26 9
Sunday, April 26
08:30-10:00
Clinical Focus Session
CF 101 Metastatic colorectal cancer
Moderators: D. Arnold (Hamburg/DE), P.L. Pereira (Heilbronn/DE)
101.1 Patient selection for locoregional treatment on a molecular basis
C.T. Sofocleous (New York, NY/US)
101.2 Patient selection for locoregional treatment: clinical selection
D. Arnold (Hamburg/DE)
101.3 Update on ablation results in colorectal liver mets
M.R. Meijerink (Amsterdam/NL)
101.4 Combined approach to extend curative treatment
A. Denys (Lausanne/CH)
101.5 Intra-arterial therapies: where are we now?
F. Orsi (Milan/IT)
101.6 Lung metastases local treatment
T. de Baère (Villejuif/FR)
10:30-12:00
Clinical Focus Session
CF 201 Cancer immunotherapy: clinical results
Moderators: J. Haanen (Amsterdam/NL), C. Ottensmeier (Southampton/UK)
201.1 Immunotherapy in 2020: clinical indications
G. Curigliano (Milan/IT)
201.2 Checkpoint inhibitors in HCC, lung and renal tumours
U. Martens (Heilbronn/DE)
201.3 Beyond checkpoint inhibitors
V. Gambardella (Valencia/ES)
201.4 Pseudo-, oligo-, and hyperprogression: clinical impact
S. Champiat (Villejuif/FR)
201.5 Resistance to systemic immunotherapy: how to overcome
J. Haanen (Amsterdam/NL)
10:30-12:00
Technical Focus Session
TF 202 Image guidance: case-based discussion
Moderators: X. Buy (Bordeaux/FR), A. Fohlen (Caen/FR)
201.1 How to enhance conspicuity for hardly visible tumours
A. Hocquelet (Lausanne/CH)
201.2 How to confirm the ablation is complete
F.T. Lee (Madison, WI/US)
201.3 Combined CT and angio systems over CBCT: pro
B. Guiu (Montpellier/FR)
201.4 Combined CT and angio systems over CBCT: con
M.J.L. van Strijen (Nieuwegein/NL)
201.5 Tumour feeder detection: software solutions and clinical results
V. Tacher (Creteil/FR)
201.6 Does guidance improve results?
R. Bale (Innsbruck/AT)
recommended for EBIR preparation10 Sunday, April 26 European Conference on Interventional Oncology
10:30-12:00
Hands-on Device Training
TA-HDT 1 Tumour ablation – Radiofrequency
Coordinators: J.M. Abadal (Madrid/ES), F. Orsi (Milan/IT)
10:30-12:00
Hands-on Training
SED 1 Safe sedation application during IR procedures (basic)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
13:00-14:30
Satellite Symposia
13:00-14:30
Hands-on Training
SED 2 Safe sedation application during IR procedures (basic)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
15:00-16:30
Clinical Focus Session
CF 401 Hepatocarcinoma: from classification to treatment
Moderators: M. Fuchs (Munich/DE), R. Lencioni (Pisa/IT)
401.1 Critical view on HCC classification
M. Ronot (Clichy/FR)
401.2 Borderline in HCC nodules: the early stage
P.L. Pereira (Heilbronn/DE)
401.3 Borderline in HCC nodules: the intermediate stage
R. Golfieri (Bologna/IT)
401.4 Trials vs. reality: what is the role of radioembolisation?
E. Garin (Rennes/FR)
401.5 HCC and systemic treatment in 2020
B. Sangro (Pamplona/ES)
Round table discussion
Preliminary ProgrammeECIO 2020 Sunday, April 26 11
15:00-16:30
Clinical Focus Session
CF 402 Other organs ablation
Moderators: J. Garnon (Strasbourg/FR), to be announced
402.1 Adrenal
R.L. Cazzato (Strasbourg/FR)
402.2 Breast: local
J. Palussière (Bordeaux/FR)
402.3 Pancreas: local
H.J. Scheffer (Amsterdam/NL)
402.4 Lymph nodes
G. Tsoumakidou (Lausanne/CH)
402.5 Thyroid cancer
R. Cervelli (Pisa/IT)
402.6 Soft tissue tumour
T.K. Helmberger (Munich/DE)
15:00-16:30
Hands-on Device Training
TA-HDT 2 Tumour ablation – Radiofrequency
Coordinators: J.M. Abadal (Madrid/ES), F. Orsi (Milan/IT)
15:00-16:30
Hands-on Training
SED 3 Safe sedation application during IR procedures (advanced)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
17:00-18:30
Clinical Focus Session
CF 501 HCC: patient management
Moderators: M. Ikeda (Tokyo/JP), K. Malagari (Athens/GR)
501.1 Current status of biopsy in HCC
J. Bell (Manchester/UK)
501.2 From bridging and downstaging to transplantation
to be announced
501.3 The bleeding HCC tumour: management and outcomes
M. Burrel (Barcelona/ES)
501.4 HCC with portal vein invasion
R. Salem (Chicago, IL/US)
501.5 HCC in non-cirrhotic liver
H. Pinto Marques (Lisbon/PT)
501.6 Combining locoregional treatment and immunotherapy in 2020
P. Reimer (Karlsruhe/DE)
recommended for EBIR preparation12 Sunday, April 26 European Conference on Interventional Oncology
17:00-18:30
Clinical Focus Session
CF 502 Nuclear medicine and interventional oncology – present and future
Moderators: H. Ilhan (Munich/DE), M.G.E.H. Lam (Utrecht/NL)
502.1 New targets in nuclear medicine opportunities for IO
N. Schaefer (Lausanne/CH)
502.2 Intra-arterial PRRT liver metastases from NET
to be announced
502.3 Kidney and lung radioembolisation
J. Ricke (Munich/DE)
502.4 PET PSMA and prostate cancer
to be announced
502.5 Yttrium, Holmium, Radium, etc.
M.G.E.H. Lam (Utrecht/NL)
502.6 Lipiodol in nuclear medicine is back
E. Garin (Rennes/FR)
17:00-19:00
Basic Course
BC 503 GU primer and adrenal disease
Moderator: R.F. Grasso (Rome/IT)
503.1 Arterial and venous anatomy of the kidney and adrenal gland
L. Tselikas (Paris/FR)
503.2 Optimising renal embolisation after iatrogenic injury
T. Bryant (Southampton/UK)
503.3 Adrenal ablation: when and how?
R.F. Grasso (Rome/IT)
503.4 Urological bone metastases: when and how to treat?
F. Deschamps (Villejuif/FR)
503.5 Focal urological bone metastases: case for ablation versus SBRT
A.N. Kurup (Rochester, MN/US)
18:30-19:15
Satellite Symposia
Preliminary ProgrammeECIO 2020 Monday, April 27 13
Monday, April 27
08:00-08:20
Satellite Symposia
08:30-10:00
Clinical Focus Session
CF 801 Cholangiocarcinoma
Moderators: T.K. Helmberger (Munich/DE), P.L. Pereira (Heilbronn/DE)
801.1 Imaging of perihilar carcinoma
A. Guthrie (Leeds/UK)
801.2 Perihilar cholangiocarcinoma: staging and surgical results
G. Kazemier (Amsterdam/NL)
801.3 Endobiliary treatments of PCC: from light to waves
V. Válek (Brno/CZ)
801.4 Percutaneous ablative treatments of PCC and mass forming cholangiocarcinoma
K.P. van Lienden (Amsterdam/NL)
801.5 Systemic treatment for cholangiocarcinoma
J. Bridgewater (London/UK)
801.6 Intra-arterial treatments for cholangiocarcinoma
F. Wacker (Hannover/DE)
08:30-10:00
Clinical Focus Session
CF 802 IO 4 IO
Moderators: G. Adema (Nijmegen/NL), N. Goldberg (Jerusalem/IL)
802.1 Local delivery of immunotherapy: drugs candidates
S. Champiat (Villejuif/FR)
802.2 Local delivery of immunotherapy: routes
T. de Baère (Villejuif/FR)
802.3 Local delivery of immunotherapy: results
J. Brody (New York, NY/US)
802.4 Ablation and immunomodulation: the best scheme and technique
S. Haen (Tübingen/DE)
802.5 Intra-arterial treatments and immunomodulation: the best scheme and technique
R. Duran (Lausanne/CH)
802.6 Combining IO treatment and systemic immunotherapy: clinical results
A. Digklia (Lausanne/CH)
08:30-10:00
Hands-on Training
SED 4 Safe sedation application during IR procedures (basic)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
recommended for EBIR preparation14 Monday, April 27 European Conference on Interventional Oncology
10:30-11:30
HL 901 Honorary Lecture
Moderators: P. Chevallier (Nice/FR), A. Gangi (Strasbourg/FR)
Laudation: E. Brountzos (Athens/GR)
901.1 History of chemoembolisation of the liver: novelties and clinical practice –
the evolution of research methodology
K. Malagari (Athens/GR)
10:30-12:00
Hands-on Device Training
TA-HDT 3 Tumour ablation – Microwave
Coordinators: S. Ilyas (London/UK), P.P. Rao (Colmar/FR)
10:30-12:00
Hands-on Training
SED 5 Safe sedation application during IR procedures (advanced)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
11:30-12:00
Free Paper Session
FP 902 Free Papers 1
Moderators: P. Chevallier (Nice/FR), A. Gangi (Strasbourg/FR)
12:15-13:00
ECIO meets
EM 1001 ECIO meets JSIR
Moderators: Y. Arai (Tokyo/JP), A. Denys (Lausanne/CH)
1001.1 Technical innovation of TACE in Japan
T. Tanaka (Kashihara/JP)
1001.2 RFA for lung metastasis
K. Yamakado (Osaka/JP)
1001.3 Challenges in clinical trials of palliative IO: Japanese perspective
M. Sone (Tokyo/JP)
13:00-14:30
Satellite Symposia
13:00-14:30
Hands-on Training
SED 6 Safe sedation application during IR procedures – (advanced, focus on propofol)
Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
Preliminary ProgrammeECIO 2020 Monday, April 27 15
15:00-16:30
Clinical Focus Session
CF 1101 Primary lung tumours
Moderators: J. Palussière (Bordeaux/FR), to be announced
1101.1 Biopsies of lung tumours
J.Y. Gaubert (Marseille/FR)
1101.2 Stage I surgery: sub lobar, VATS, robotics and results
to be announced
1101.3 Early-stage tumours: indications & limitations of SBRT
S. Heymann (Strasbourg/FR)
1101.4 Early-stage tumours: results of thermal ablation
R.D. Suh (Los Angeles, CA/US)
1101.5 Oligometastatic lung cancer: optimal management
S.B. Solomon (New York, NY/US)
1101.6 New concepts in lung cancer
C. Ottensmeier (Southampton/UK)
15:00-16:30
Clinical Focus Session
CF 1102 IO to optimise liver surgery
Moderators: A. Denys (Lausanne/CH), J.-N. Vauthey (Houston, TX/US)
1102.1 Liver failure after surgery: definition and risk factors
A. Iannelli (Nice/FR)
1102.2 How to better predict liver function: MR with primovist, CT volumetry, and Mebrofenin scintigraphy
M. Ronot (Clichy/FR)
1102.3 ALPPS: a critical review
J.-N. Vauthey (Houston, TX/US)
1102.4 Radioembolisation is the best way to promote liver growth
R. Salem (Chicago, IL/US)
1102.5 Portal vein embolisation: technical issues
J.H. Luz (Lisbon/PT)
1102.6 PVE: liver venous deprivation
B. Guiu (Montpellier/FR)
15:00-16:30
Hands-on Device Training
TA-HDT 4 Tumour ablation – Microwave
Coordinators: S. Ilyas (London/UK), P.P. Rao (Colmar/FR)
recommended for EBIR preparation16 Monday, April 27 European Conference on Interventional Oncology
17:00-18:30
Clinical Focus Session
CF 1201 Robotics and AI
Moderators: L. Solbiati (Rozzano/IT), to be announced
1201.1 Artificial intelligence in oncology
to be announced
1201.2 Artificial intelligence in interventional oncology
J. Chapiro (New Haven, CT/US)
1201.3 Augmented reality in IO
F. Wacker (Hannover/DE)
1201.4 Treatment planification
A. King (Southampton/UK)
1201.5 Robotics for ablation
K. de Jong (Groningen/NL)
1201.6 Robotics, AI, ...where is the future heading?
B.J. Wood (Bethesda, MD/US)
17:00-18:30
Clinical Focus Session
CF 1202 MSK: curative treatment in oligometastatic bone disease
Moderators: M.R. Callstrom (Rochester, MN/US), A. Gangi (Strasbourg/FR)
1202.1 Who is the ideal candidate for local treatment?
M.R. Callstrom (Rochester, MN/US)
1202.2 SBRT – results for complete local remission
S. Heymann (Strasbourg/FR)
1202.3 Ablation tools and how to use them
J.W. Jennings (Saint Louis, MO/US)
1202.4 Avoiding complications: tips and tricks
R.L. Cazzato (Strasbourg/FR)
1202.5 Results of ablation
R.-T. Hoffmann (Dresden/DE)
1202.6 Challenges in imaging follow-up: ablation vs. SBRT
A.D. Kelekis (Athens/GR)
17:00-19:00
Basic Course
BC 1203 Renal cancer ablation
Moderator: D.J. Breen (Southampton/UK)
1203.1 Epidemiology: when to treat and when not to treat?
T.K. Nielsen (Aarhus/DK)
1203.2 Renal cancer biopsy: when and how best done?
T.M. Wah (Leeds/UK)
1203.3 Renal cancer ablation: optimal technique
D.J. Breen (Southampton/UK)
1203.4 Avoiding and managing complications
G.D. Schmit (Rochester, MN/US)
1203.5 Understanding the current outcome data compared to surgery
O. Graumann (Odense/DK)
18:30-19:15
Satellite SymposiaECIO 2020 Tuesday, April 28 17
Tuesday, April 28
08:00-08:20
Satellite Symposia
08:30-10:00
Clinical Focus Session
CF 1501 Renal cancer ablation: moving forward
Moderators: A. Bex (Amsterdam/NL), D.J. Breen (Southampton/UK)
1501.1 T1 renal disease: scope of the problem
T.K. Nielsen (Aarhus/DK)
1501.2 How to manage renal cancer syndromes
E. Woodward (Manchester/UK)
1501.3 Ablation and surgery: functional impact?
O. Graumann (Odense/DK)
1501.4 Surgery for T1 renal tumours: current trends
A. Bex (Amsterdam/NL)
1501.5 Optimising renal tumour ablation
D.J. Breen (Southampton/UK)
1501.6 Renal tumour ablation: avoiding complications
G.D. Schmit (Rochester, MN/US)
08:30-10:00
Clinical Focus Session
CF 1502 Upcoming European research
Moderators: M.R. Meijerink (Amsterdam/NL), S.B. Solomon (New York, NY/US)
1502.1 Intratumoral immunotherapy
L. Tselikas (Villejuif/FR)
1502.2 Cryo priming in immunoresponse
R. Duran (Lausanne/CH)
1502.3 Combining IRE and immunotherapy
H.J. Scheffer (Amsterdam/NL)
1502.4 Serum and tumoral biomarkers can predict recurrence after HCC locoregional therapies
R. Muglia (Rozzano/IT)
1502.5 Endothelial antibody capture – a potential strategy for innovative locoregional tumor diagnosis and treatment
C.-M. Sommer (Heidelberg/DE)
1502.6 Direction of travel for IO research
N. Goldberg (Jerusalem/IL)
recommended for EBIR preparation18 Tuesday, April 28 European Conference on Interventional Oncology
10:30-12:00
Clinical Focus Session
CF 1601 Challenges in IO
Moderators: G. Narayanan (Miami, FL/US), G.M. Varano (Milan/IT)
1601.1 IO in pediatrics
A.M. Barnacle (London/UK)
1601.2 Chemosaturation: FOCUS study results
B. Stedman (Southampton/UK)
1601.3 Central liver tumours: we don‘t need IRE
P. Chevallier (Nice/FR)
1601.4 Central liver tumours: IRE is the solution
O. Seror (Bondy/FR)
1601.5 Starting an MR-guided programme
A. King (Southampton/UK)
1601.6 Brain tumours: IO solutions
G. Gahide (Montreal/CA)
10:30-12:00
Clinical Focus Session
CF 1602 Palliation in oncology
Moderators: J.K. Bell (Manchester/UK), T.J. Kroencke (Augsburg/DE)
1602.1 Abdominal neurolysis: optimising results
D.K. Filippiadis (Athens/GR)
1602.2 Improving nutrition in cancer patients
H.-U. Laasch (Manchester/UK)
1602.3 Ascites in cancer patients
G. Maleux (Leuven/BE)
1602.4 Bleeding complications after radiotherapy: how to manage
L. Tselikas (Villejuif/FR)
1602.5 Palliation of carcinoid syndrome
J. Urbano (Madrid/ES)
1602.6 Vascular complications after Whipple procedure
D. Poretti (Rozzano/IT)
10:30-12:00
Hands-on Device Training
TA-HDT 5 Tumour ablation – Cryo- and laser
Coordinators: A.H. Mahnken (Marburg/DE), G. Mauri (Milan/IT)
13:00-14:30
Satellite Symposia
Preliminary ProgrammeECIO 2020 Tuesday, April 28 19
15:00-16:30
Clinical Focus Session
CF 1801 MSK palliation: the pelvic bone
Moderators: J.W. Jennings (St. Louis, MO/US), A.D. Kelekis (Athens/GR)
1801.1 Biomechanics and anatomy of the pelvic bone
J. Garnon (Strasbourg/FR)
1801.2 Clinical and radiological evaluation
S. Bauones (Riad/SA)
1801.3 Surgery: what is feasible and what is reasonable?
M. Jayankura (Brussels/BE)
1801.4 Percutaneous cementoplasty
A.N. Kurup (Rochester, MN/US)
1801.5 Percutaneous screw fixation
F. Deschamps (Villejuif/FR)
1801.6 When and how to ablate
D.K. Filippiadis (Athens/GR)
15:00-16:30
Video Learning Session
VL 1802 How I do it
Moderators: I. Bargellini (Pisa/IT), C.T. Sofocleous (New York, NY/US)
1802.1 Hepatic intra-arterial port
Y. Arai (Tokyo/JP)
1802.2 MR-guided prostate interventions
J.J. Fütterer (Nijmegen/NL)
1802.3 Organ protection and ablation
R. Iezzi (Rome/IT)
1802.4 Liver venous deprivation: transjugular approach
A. Hocquelet (Lausanne/CH)
1802.5 Chemosaturation
G.M. Varano (Milan/IT)
1802.6 Pancreatic IRE
G. Narayanan (Miami, FL/US)
15:00-16:30
Hands-on Device Training
TA-HDT 6 Tumour ablation – Image guidance
Coordinators: R. Bale (Innsbruck/AT), A. Hakimé (Villejuif/FR)
recommended for EBIR preparation20 Tuesday, April 28 European Conference on Interventional Oncology
17:00-18:30
Clinical Focus Session
CF 1901 Imaging and clinical follow-up
Moderators: C. Ayuso (Barcelona/ES), to be announced
1901.1 Liver ablation
L. Crocetti (Pisa/IT)
1901.2 Liver chemoembolisation
E. Coimbra (Lisbon/PT)
1901.3 Liver radioembolisation
I. Bargellini (Pisa/IT)
1901.4 Kidney ablation
J. Correas (Paris/FR)
1901.5 Lung ablation and SBRT
R.D. Suh (Los Angeles, CA/US)
1901.6 Pancreas ablation
to be announced
17:00-18:30
Free Paper Session
FP 1902 Free Papers 2
17:00-19:00
Basic Course
BC 1903 Prostate cancer
Moderator: J.J Fütterer (Nijmegen/NL)
1903.1 Scope of the problem and where IO can help
T. Dudderidge (Southampton/UK)
1903.2 Prostate anatomy: relevance to ablation
R.L. Cazzato (Strasbourg/FR)
1903.3 Best ablation tools and image guidance
B.J. Wood (Bethesda, MD/US)
1903.4 The case for MR-targeted biopsy and focal ablation
S. Jenniskens (Nijmegen/NL)
1903.5 MR-guided prostate cryoablation: the way to go?
J.J Fütterer (Nijmegen/NL)
18:30-19:15
Satellite Symposia
Preliminary ProgrammeECIO 2020 Wednesday, April 29 21
Wednesday, April 29
08:30-10:00
Technical Focus Session
TF 2101 Tips and tricks: case-based discussion
Moderators: O. Akhan (Ankara/TR), R.D. García-Mónaco (Buenos Aires/AR)
2101.1 Lymphatic leaks
F. Douane (Nantes/FR)
2101.2 Combined TACE and ablation
T.F. Jakobs (Munich/DE)
2101.3 Nerve protection in the pelvis
A.N. Kurup (Rochester, MN/US)
2101.4 Liver: complex biliary procedures
D.W. de Boo (New Lambton Heights/AU)
2101.5 Portal vein occlusion after abdominal surgery
J. Bell (Manchester/UK)
2101.6 Extrahepatic feeders for TACE
S.J. Park (Incheon/KR)
08:30-10:00
Clinical Focus Session
CF 2102 Different ways of killing cancer – and why we need all of them
Moderators: A. Adam (London/UK), L.M. Kenny (Brisbane/AU)
2102.1 Thermal ablation: RFA, MWA and HIFU – their advantages and limitations
N. Goldberg (Jerusalem/IL)
2102.2 Photons (fractionated radiotherapy and SABR): selective death and total destruction
L.M. Kenny (Brisbane/AU)
2102.3 Cryotherapy: precise but dangerous if not used carefully
A. Gangi (Strasbourg/FR)
2102.4 Particle therapy: will it redefine imaging-guided treatment?
J. Doyen (Nice/FR)
Panel discussion
10:30-12:00
MM 2201 Morbidity & Mortality
Coordinators: T. Bilhim (Lisbon/PT), D. Poretti (Rozzano/IT)
e-voting recommended for EBIR preparation22 Basic Course European Conference on Interventional Oncology
Basic Course
Genitourinary
This format aims to offer a basic course series for beginners, Sunday, April 26
focusing on a different organ each year. At ECIO 2020, BC 503 – GU primer and adrenal disease 17:00-19:00
the topic of this six-hour course will be Genitourinary and Moderator: R.F. Grasso (Rome/IT)
will feature three distinct sessions, structured by the content
included in the new European Curriculum and Syllabus 503.1 Arterial and venous anatomy of the kidney
for IR. It will allow a limited number of participants to receive and adrenal gland
a comprehensive overview of the topic, from diagnostics, L. Tselikas (Paris/FR)
imaging, treatment and follow-up. 503.2 Optimising renal embolisation after iatrogenic injury
T. Bryant (Southampton/UK)
503.3 Adrenal ablation: when and how?
R.F. Grasso (Rome/IT)
503.4 Urological bone metastases: when and how to treat?
F. Deschamps (Villejuif/FR)
503.5 Focal urological bone metastases: case for ablation
versus SBRT
A.N. Kurup (Rochester, MN/US)
Monday, April 27
BC 1203 – Renal cancer ablation 17:00-19:00
Moderator: D.J. Breen (Southampton/UK)
1203.1 Epidemiology: when to treat and when not to treat?
T.K. Nielsen (Aarhus/DK)
1203.2 Renal cancer biopsy: when and how best done?
T.M. Wah (Leeds/UK)
1203.3 Renal cancer ablation: optimal technique
D.J. Breen (Southampton/UK)
1203.4 Avoiding and managing complications
G.D. Schmit (Rochester, MN/US)
1203.5 Understanding the current outcome data compared
to surgery
O. Graumann (Odense/DK)
Tuesday, April 28
BC 1903 – Prostate cancer 17:00-19:00
Moderator: J.J. Fütterer (Nijmegen/NL)
1903.1 Scope of the problem and where IO can help
T. Dudderidge (Southampton/UK)
1903.2 Prostate anatomy: relevance to ablation
R.L. Cazzatto (Strasbourg/FR)
1903.3 Best ablation tools and image guidance
B.J. Wood (Bethesda/US)
How to participate: 1903.4 The case for MR-targeted biopsy and focal ablation
S. Jenniskens (Nijmegen/NL)
Participation is free of charge, but places are limited 1903.5 MR-guided prostate cryoablation: the way to go?
and will be allocated on a first come, first served basis. J.J. Fütterer (Nijmegen/NL)
Preliminary ProgrammeECIO 2020 Hands-on Device Training 23
Hands-on Device Training
Tumour ablation
Percutaneous ablation plays an increasingly fundamental Sunday, April 26
role for the loco-regional treatment of cancer. Ablation TA-HDT 1 – Radiofrequency 10:30-12:00
technologies and equipment for live image guidance are TA-HDT 2 – Radiofrequency 15:00-16:30
developing quickly.
Coordinators: J.M. Abadal (Madrid/ES), F. Orsi (Milan/IT)
This Hands-on Device Training (HDT) aims to provide an
overview of available technologies. Separate sessions will look
at radiofrequency ablation, microwave ablation, cryoablation Monday, April 27
and laser ablation, as well as image guidance. TA-HDT 3 – Microwave 10:30-12:00
TA-HDT 4 – Microwave 15:00-16:30
After a short kick-off presentation by the HDT coordinators,
participants will have the opportunity to learn about the Coordinators: S. Ilyas (London/UK), P.P. Rao (Strasbourg/FR)
specifics, as well as the safe and effective use of the available
technology in a hands-on setting.
Tuesday, April 28
Each HDT will feature a round-table discussion with the TA-HDT 5 – Cryoablation and 10:30-12:00
coordinators at the end of each session allowing participants laser ablation
to ask questions and give feedback.
Coordinators: A.H. Mahnken (Marburg/DE), G. Mauri (Milan/IT)
TA-HDT 6 – Image guidance 15:00-16:30
Coordinators: R. Bale (Innsbruck/AT), A. Hakimé (Villejuif/FR)
How to participate:
Participation is free of charge, but places are limited
and will be allocated on a first come, first served basis.
As all these sessions offer practical medical training,
participation is for qualified medical professionals only.24 Safe sedation application European Conference on Interventional Oncology
Safe sedation application during
IR procedures
This practical workshop will give participants the opportunity Learning objectives
to perform procedural sedation in a simulated environment
and learn about the most common respiratory complications, • To apply procedural sedation using various approaches
as well as which instruments are available to make these • To identify complications and challenges during
interventions safer. procedural sedation
• To assess the value of various monitoring technologies
These training sessions are carried out on a full-scale patient • To recognise the added value of capnography during
simulator with capnography, BIS monitoring and TIVA/TCI sedation
pumps. Participants will perform these therapies under the • To select appropriate sedation techniques in
supervision of AQAI’s experienced trainers. high-risk patients
• To identify limitations and situations where the help
In the advanced sessions, participants can additionally perform of an anaesthesiologist is mandatory
sedations for high-risk patients, e.g. those with hypertonia,
severe cardiac diseases or pulmonary diseases like COPD. Coordinators: M. Heinrichs (Mainz/DE), W. Heinrichs (Mainz/DE)
Participants in these sessions should visit a basic session first
or should have substantial experience in procedural sedation. Sunday, April 26
SED 1 – Basic 10:30-12:00
One of the available sessions will focus on the use of propofol SED 2 – Basic 13:00-14:30
and will provide training for sedation using this drug for SED 3 – Advanced 15:00-16:30
repeated boluses, during continuous infusion techniques
and during the TCI (target controlled infusion) technique. Monday, April 27
The workshop will specifically explore the possible safety SED 4 – Basic 08:30-10:00
issues associated with propofol. To participate in this session, SED 5 – Advanced 10:30-12:00
attendees should have already attended a basic session SED 6 – Advanced (focus on propofol) 13:00-14:30
and should have some basic knowledge about the special
pharmacology of propofol. Please note that as the use of
propofol by non-anaesthesiologists is strictly forbidden in
some countries, this may be a limitation for some interested
participants.
How to participate:
Participation is free of charge, but places are limited
and will be allocated on a first come, first served basis.
As all these sessions offer practical medical training,
participation is for qualified medical professionals only.
Preliminary ProgrammeECIO 2020 Registration / CME / Important Addresses 25
Registration
Online registration (secured payment) for ECIO 2020 Cancellation of congress registration
is available at www.ecio.org. CIRSE GmbH offers all pre-registered participants the
possibility to take out cancellation insurance with its partner
Please note that your registration must be submitted and full "Europäische Reiseversicherung". The insurance can only be
payment needs to be received by the respective registration booked during and until finalisation of the online registration
deadlines. Otherwise the respective next higher fee will process. The refund of the participant‘s registration fee due to
be due. Furthermore, please be advised that incomplete cancellation of the registration or the change of registration
registrations (not containing full name, email and address) category is only possible with a valid insurance. All requests
cannot be processed. must be made to "Europäische Reiseversicherung" directly.
Refunds will be given according to the terms and conditions
Registration Fees of the "Europäische Reiseversicherung". CIRSE GmbH shall not
be responsible for any refunds of registration fees.
Early – until January 16, 2020 (23:59 CET)
Congress Registration € 610 Name changes will be handled as a cancellation and new
CIRSE Member € 410 registration.
Resident € 320
Resident Member € 270
Nurse / Radiographer* € 270 Additional information
Undergraduate Medical Student** € 0 All ECIO 2020 registrants will be able to print out an invoice of
registration using their personal login details at www.ecio.org.
Middle – until March 5, 2020 (23:59 CET)
Congress Registration € 810 Invoices will be issued by: CIRSE Congress Innovation
CIRSE Member € 570 Research GmbH, Neutorgasse 9/6, 1010 Vienna, Austria
Resident € 455
Resident Member € 405
Nurse / Radiographer* € 405 CME Credit Allowance
Undergraduate Medical Student** € 0
An application will be made to the EACCME®
Late – until April 24, 2020 for CME accreditation of ECIO 2020.
Congress Registration € 880
CIRSE Member € 770
Resident € 490 Important Addresses
Resident Member € 440
Nurse / Radiographer* € 440 Congress Venue
Undergraduate Medical Student** € 0 Palais des Congrès Nice Acropolis
1 Esplanade Kennedy
Onsite – from April 25, 2020 06364 Nice Cedex 4, France
Congress Registration € 980
CIRSE Member € 870 Organising Secretariat
Resident € 590 CIRSE Central Office
Resident Member € 540 Neutorgasse 9
Nurse / Radiographer* € 540 1010 Vienna, Austria
Undergraduate Medical Student** € 0 Phone: +43 1 904 2003
Fax: +43 1 904 2003 30
* To be accompanied by a certificate, signed by the head of department. Email: info@cirse.org
** To be accompanied by a confirmation of student status at the time Web: www.ecio.org
of congress, a one-page CV and a copy of a valid photo ID.
Registration fee inclusive 21% VAT in France.
Email Contacts
For general enquiries about the ECIO 2020 meeting, please
Reduced CIRSE Member registration is only available send an email to info@cirse.org.
for members of CIRSE (Cardiovascular and Interventional
Radiological Society of Europe) in good standing. In the case of queries concerning registration for the ECIO 2020
meeting, please send an email to registration@ecio.org.
Method of payment
Registration fees are to be paid in Euros (€) by: For information about the scientific programme of ECIO 2020,
Bank transfer or Credit Card (Visa or Mastercard) please send an email to scientific@cirse.org.26 Accommodation / City Map European Conference on Interventional Oncology
Accommodation
In cooperation with our travel partner Kuoni Congress, If you have any questions, please do not hesitate to contact
CIRSE has secured a great number of hotel rooms in Nice
for the benefit of our congress participants. Kuoni Congress
Contact: Viera Bacova & Karin Amstler
For further information about the official ECIO hotels and ecio2020@kuoni-congress.com
room bookings, please refer to www.ecio.org. +420 296 301 204
List of hotels
Hotel name Category Single room (€) Double room (€)
WALKING PUBLIC TAXI
1 Aston La Scala Hotel 4* 181,20 198,40 15 min 5 min
2 Beau Rivage Nice Hotel 4* 181,20 198,40 15 min 10 min
3 Ellington Nice Centre 4* 162,20 174,40 10 min 5 min
4 Hipark by Adagio 4* 113,20 124,40 5 min - -
5 Holiday Inn Nice 4* 182,20 199,40 20 min 10 min
6 Hyatt Regency Nice 5* 253,00 276,00 20 min 10 min
7 Le Meridien Nice 4* 237,20 254,40 20 min 10 min
8 Masséna Best Western Plus Nice 4* 193,20 205,40 15 min 10 min
9 NH Nice 4* 177,20 190,90 5 min - -
10 Nice Riviera 4* 147,20 169,40 15 min 10 min
11 Novotel Nice Centre Vieux 4* 171,20 192,40 5 min - -
All room rates are in Euro (EUR) inclusive of breakfast, VAT and city tax based on 2020. Please note, that all taxes and service charges
are subject to change according to the official legislation.
Preliminary ProgrammeECIO 2020 Accommodation / City Map 27
11 9
Riquier
so
is
M a th 4
Ris
re
ie r
e ni
Bou
eP Congress Centre
alli
i lev
Vo ard
eG
Car
ab a
ard
nu
cel
lev
Ave
Bou
Ru e
Bar
la
3
Carabacel
5 10
ure
Mont Boron
Fa
8 Félix
1 nu e
Jean-Médecin Ave
rès
Jau
d J ean
ar
Bo ul e v Vielle Ville Boulevard
Ca
rno
2
t
6 7 Prom. des Anglais
lais
.d e s A ng
Prom
YOUR OFFICIAL CARRIER FOR ECIO 2020
Registered participants traveling to ECIO 2020 are invited to take advantage of a discount of up
to 10% when booking their flight with Lufthansa Group Partner Airlines!
Lufthansa Group Partner Airlines offer a comprehensive global route network linking major cities
around the world. To make a reservation, please visit www.ecio.org/attend/flights-discounts/
and enter the following access code: ATZQXBJ
Special rates are offered on flights operated by Austrian, Lufthansa, Swiss, Brussels Airlines and
Eurowings and are valid from April 19 until May 6, 2020. Some flights to Nice with Air Canada
or United Airlines flight numbers are also eligible for the discount.
We look forward to welcoming you to Nice!CVIR: your journal for IO research
Publish in CVIR Focus
to reach an on IO
international audience!
• more than 8,000 subscribers
• official organ of over 20 national IR societies
• a dedicated IO section in each monthly issue
Recent highlights include a special section
on oncology in the September 2019 issue,
edited by Prof. Thierry de Baère
www.cvironline.org
jan 2019
vol 42 | no 1 |ECIO 2020 29
The European Conference on Interventional Oncology ECIO 2020 Preliminary Programme
is organised by CIRSE (Cardiovascular and Interventional In case of any enquiries or comments,
Radiological Society of Europe). please contact us at info@cirse.org
The official congress website is: www.ecio.org © Cardiovascular and Interventional Radiological
Society of Europe / 2019
To contact the CIRSE Central Office or members of the
committee please write to info@cirse.org. CIRSE does not accept responsibility for errors or misprints.
Cover: Place Massena and Fountain du Soleil at Dawn
Nice, France
© www.shutterstock.com
GraphX by L O O P . E N T E R P R I S E S media
www.loop-enterprises.comPreliminary Programme
You can also read
